N
SWAV

Natixis’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Natixis’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,346
Closed -$6.3M – 1187
2024
Q1 		$6.3M Buy
19,346
+10,810
+127% +$2.65M 0.03% 288
2023
Q4 		$1.63M Buy
8,536
+8,012
+1,529% +$1.51M 0.01% 442
2023
Q3 		$104K Buy
+524
New +$124K ﹤0.01% 782
2023
Q2 		– Sell
-15,570
Closed -$3.38M – 1171
2023
Q1 		$3.38M Sell
15,570
-15,939
-51% -$3.11M 0.03% 331
2022
Q4 		$6.48M Buy
31,509
+13,834
+78% +$3.5M 0.04% 338
2022
Q3 		$5.12M Sell
17,675
-4,387
-20% -$1.12M 0.02% 404
2022
Q2 		$4.3M Sell
22,062
-8,640
-28% -$1.53M 0.02% 478
2022
Q1 		$6.37M Sell
30,702
-2,086
-6% -$344K 0.02% 500
2021
Q4 		$5.85M Sell
32,788
-1,500
-4% -$296K 0.02% 520
2021
Q3 		$7.06M Buy
+34,288
New +$6.73M 0.02% 450
2021
Q2 		– Sell
-37,296
Closed -$4.86M – 1162
2021
Q1 		$4.86M Buy
37,296
+5,106
+16% +$612K 0.02% 517
2020
Q4 		$3.34M Sell
32,190
-1,221
-4% -$106K 0.01% 591
2020
Q3 		$2.53M Buy
33,411
+3,370
+11% +$191K 0.02% 377
2020
Q2 		$1.42M Buy
+30,041
New +$1.24M 0.01% 467

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Natixis's SWAV Position: Q2 2024 in Review

Natixis sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 19,346 shares — an estimated $6.3M sold.

Natixis first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $7.06M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Natixis reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Natixis sold 19,346 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $6.3M.
  • Natixis first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Natixis's Shockwave Medical, Inc. Common Stock position peaked at $7.06M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.